| 英文名 | 6-(3-methyl-1-tritylpyrazol-4-yl)pyridine-3-carbonitrile |
|---|---|
| 英文别名 |
6-(3-methyl-1-trityl-1H-pyrazol-4-yl)-nicotinonitrile
3-Pyridinecarbonitrile,6-[3-methyl-1-(triphenylmethyl)-1H-pyrazol-4-yl] |
| 分子式 | C29H22N4 |
|---|---|
| 分子量 | 426.51200 |
| 精确质量 | 426.18400 |
| PSA | 54.50000 |
| LogP | 5.96538 |
|
~51%
857531-67-0 |
| 文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2006/136821 A1, 2006 ; Location in patent: Page/Page column 117-118 ; WO 2006/136821 A1 |